AstraZeneca gets first supply deals for COVID vaccine, eyes late stage trials

AstraZeneca gets first supply deals for COVID vaccine, eyes late stage trials
Reuters: Health
AstraZeneca Plc said on Thursday it had received the first agreements to supply at least 400 million doses of the COVID-19 vaccine it is developing with the University of Oxford.


No comments:

Post a Comment